(Downloadable video soundbites and lab b-roll) Scientist David Baker discusses creating proteins custom tailored to specific therapeutic targets. See related story.
Type: Upload file
Artist impression of designed mini-protein binders targeting Influenza hemagglutinin to effectively bind and neutralize the virus.
It's the question many ask: Is there a safe amount to drink during pregnancy? A new study published in Advances in Pediatric Research suggests the answer is no. Susan Astley Hemingway, professor of...
Surgical oncologist Venu G. Pillarisetty talks about why resting before surgery is the worst thing you can do. Dr. Pillarisetty is senior author of study published in PLOS One finds that finds...
Researchers studying Alzheimer’s disease have created an approach to classify those patients, a finding that may be a path to personalized treatments. In the video soundbites below, general internist...
Every 15 seconds, someone in the United States sustains a traumatic brain injury resulting from external forces such as a car crash or a fall. Every five minutes, a person is disabled as a result. Dr...
The Institute for Protein Design will become an innovation hub for new therapeutics for a variety of common, serious diseases. It will also engineer new nanomaterials for industry. Through computer...
It's scary to think about, but an infection during pregnancy, whether the flu or a urinary tract infection, appears to increase a child's risk of being diagnosed with depression or autism. ...
Much is still unknown about the virus that causes COVID-19. Dr. Kristina Adams Waldorf, professor of obstetrics and gynecology at University of Washington School of Medicine, shifted her lab's focus...
A study published in the American Journal of Obstetrics and Gynecology found that COVID-19 infections severely affect pregnant women with existing health challenges. Dr. Kristina Adams Waldorf,...